TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive In Brief: Salmon To Step Down As Center Director; Becker To Relinquish Positions At MDACC September 4, 1998